Dynavax Technologies Corporation (DVAX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 11:30AM EDT. Market open.
| Previous close | 11.64 |
| Open | 11.62 |
| Bid | 11.85 x 100 |
| Ask | 11.86 x 100 |
| Day's range | 11.60 - 11.88 |
| 52-week range | 10.60 - 15.15 |
| Volume | |
| Avg. volume | 1,965,414 |
| Market cap | 1.551B |
| Beta (5Y monthly) | 1.28 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.05 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 25.75 |
PR NewswireDynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the U.S. financial markets close.
Insider Monkey11 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Best Low Price Pharma […]
Simply Wall St.Those who invested in Dynavax Technologies (NASDAQ:DVAX) five years ago are up 68%
While Dynavax Technologies Corporation ( NASDAQ:DVAX ) shareholders are probably generally happy, the stock hasn't had...
© 2024 Yahoo. All rights reserved.